TFRC and lung adenocarcinoma: TFRC (transferrin receptor) shows CLIFI distributions trending in opposite directions for lung squamous cell carcinoma (higher) and lung adenocarcinoma (lower) indicating potentially discriminatory potential between different cancers of the same organ.